| Active, not recruiting | 4 | 192 | Europe | Empagliflozin 10mg oral tablet / Semaglutide 1mg pen injector, Jardiance(R), Ozempic(R), Empagliflozin 10mg oral tablet and placebo pen injector matching semaglutide, Jardiance(R), Placebo matching empagliflozin and placebo pen injector matching semaglutide, Control / Placebo | German Diabetes Center, Boehringer Ingelheim, German Center for Diabetes Research, Federal Ministry of Health, Germany, Ministry of Innovation, Science and Research in North Rhine-Westphalia, Novo Nordisk A/S | Type 2 Diabetes, Non-alcoholic Steatohepatitis (NASH), Non-alcoholic Fatty Liver Disease (NAFLD) | 01/25 | 12/25 | | |
NCT02991365: Effect of Weight Loss on Brain Insulin Sensitivity in Humans |
|
|
| Recruiting | N/A | 40 | Europe | nasal insulin, placebo spray | University Hospital Tuebingen | Insulin Resistance | 09/24 | 12/24 | | |
| Recruiting | N/A | 30 | Europe | oral glucose tolerance test, circadian rhythm, effect of insulin on peptide transport | University Hospital Tuebingen | Obesity | 12/22 | 06/23 | | |
| Recruiting | N/A | 50 | Europe | Diet Modification Group, Regular Diet Group | University Hospital Tuebingen | Gestational Diabetes | 07/23 | 11/23 | | |
| Recruiting | N/A | 30 | Europe | Oral glucose tolerance test with double-tracer dilution and intranasal insulin spray, Oral glucose tolerance test with double-tracer dilution and intranasal placebo spray | University of Ulm | Glucose Metabolism Disorders | 12/25 | 01/26 | | |
